Julia Carrasco-Zanini1,2,3,4, Maik Pietzner5,6,7, Jonathan Davitte8

  • 1Human Genetics and Genomics, GSK Research and Development, Stevenage, UK. j.carrasco-zanini-sanchez@qmul.ac.uk.

Nature medicine
|July 22, 2024
PubMed
概括

使用稀疏的血蛋白签名可以改善早期疾病检测. 这些新型生物标志物比传统的临床数据更准确地预测常见和罕见疾病,有助于及时诊断.